PLGF anticorps (AA 166-221) (Cy5)
Aperçu rapide pour PLGF anticorps (AA 166-221) (Cy5) (ABIN727239)
Antigène
Voir toutes PLGF (PGF) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 166-221
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human PLGF
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- PLGF (PGF) (Placenta Growth Factor (PGF))
-
Autre désignation
- PLGF
-
Sujet
-
Synonyms: PGFL, PLGF, PlGF-2, D12S1900, SHGC-10760, Placenta growth factor, PGF
Background: Growth factor active in angiogenesis and endothelial cell growth, stimulating their proliferation and migration. It binds to the receptor FLT1/VEGFR-1. Isoform PlGF-2 binds NRP1/neuropilin-1 and NRP2/neuropilin-2 in a heparin-dependent manner. Also promotes cell tumor growth.
-
ID gène
- 5228
-
UniProt
- P49763
-
Pathways
- VEGFR1 Specific Signals
Antigène
-